Demographic, clinical, and patient-reported outcome data from two global, Phase 3 trials of chronic cough

Thursday, May 11th, 2023

This pooled analysis examined the medical histories and clinical characteristics of 2044 adult patients with refractory or unexplained chronic cough enrolled in the Phase 3 COUGH-1 and COUGH-2 trials. In both studies, objective 24-hour cough frequency was calculated from recordings captured using the Vitalograph VitaloJAK device.